Mandelson’s lobbying firm Global Counsel went bust owing £4.6m, report says Consultancy that advised TikTok, Palantir and GSK collapsed amid fallout over former minister’s links to Jeffrey Epstein The Guardian - UK · Apr 23
GSK reports promising early results in ovarian and womb cancer drug trial Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug The Guardian - UK · Apr 12
3 Bargain-Cheap Small Caps Worth a Second Look Three low P/E small-cap stocks offer distinct catalysts and upside potential as investors look ahead to a broader market rally MarketBeat · Apr 9
He knows the pain of Lyme disease better than anyone, but RFK Jr. is about to make a decision that has health experts terrified Here’s some big news in the fight against Lyme disease: Pfizer just announced its plan to file for regulatory approval of a new Lyme disease vaccine. If it gets the green light, this would be the first vaccine for the tick-borne illness available in over two decades. This new development,… The Mary Sue · Apr 1
Antimicrobial resistance is outpacing the industry’s efforts to fight it, report finds The antibiotic pipeline has shrunk 35 percent in five years, falling behind growing antimicrobial resistance worldwide, according to a new report. Euronews · Mar 11
Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds The Guardian - UK · Mar 10
Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise The Guardian - UK · Mar 5
Patients blame medications for triggering gambling and addictive behaviors, and the numbers are growing Medication that boost dopamine trigger compulsive and deviant behavior. We Got This Covered · Feb 24
FTSE 100 Live 19 February: Index slips, Centrica and Rio Tinto lower on results Centrica shares have fallen sharply after the British Gas owner posted results today. Evening Standard · Feb 19
GSK, take two: the bullish tone at the top is finally more convincing New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential The Guardian - UK · Feb 4
FTSE 100 tops 10,400 as Beazley and Entain soar The FTSE 100 index closed up 87.75 points, 0.9%, at 10,402.34, a new record close. Evening Standard · Feb 4
Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026 Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition The Guardian - UK · Feb 4
GSK posts higher profits but indicates sales growth to slow in 2026 It came amid the first set of results by new chief executive Luke Miels, who took over from Emma Walmsley at the turn of the year. Evening Standard · Feb 4
FTSE 100 Live 04 February: GSK milestone as index soars to new record, AI data jitters continue GSK results today helped shares surge above 2000p for the first time in over two decades as the FTSE 100 index set a new intraday record. Evening Standard · Feb 4
Evening Standard · Feb 2 GSK cutting jobs in UK and US as part of ongoing R&D changes It is understood around 50 UK jobs so far are being cut in the group’s main UK R&D hub in Stevenage, Hertfordshire.
The Independent UK · Feb 2 Drugs giant to axe up to 350 R&D jobs across the US and UK About 50 jobs will be impacted in the group’s main UK R&D hub in Stevenage, Hertfordshire
Evening Standard · Jan 28 Who is on Keir Starmer's China trip, and why are they there? A delegation of ministers, business leaders and cultural figures are part of the trip, as the Prime Minister seeks to improve relations
The Guardian - UK · Jan 20 GSK to buy food allergy drug maker RAPT in $2.2bn deal US-based biotech firm is developing treatment for allergies to nuts, milk and eggs in children and adults
Evening Standard · Jan 20 GSK acquiring firm developing food allergy treatment in £1.6bn deal The transaction is expected to complete during the first quarter of 2026.
Evening Standard · Jan 6 Next impresses as FTSE 100 rockets to fresh high Next, up 5%, impressed the City with strong Christmas sales.
MarketBeat · Jan 5 Flu Season's Here—This Dividend-Payer Controls the Shot Market With flu season in full swing, drugmakers are hoping for a short-term tailwind after a lackluster 2025. Sanofi could be the winning ticket.
The Independent UK · Dec 28, 2025 New ‘life-changing’ asthma drug gets green light after rise in hospital admissions A trial cut hospital admissions by 72 per cent
The Guardian - UK · Dec 22, 2025 Revealed: how big businesses are rolling back public support for Pride Guardian analysis of 20 major companies in UK and US shows mentions of Pride on social media have fallen substantially in past two years
The Independent UK · Dec 19, 2025 More drug companies sign on to Trump’s health exchange that promises to lower prescription prices Administration officials say the ‘Trump Rx’ website should be up and running next month